Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 12.66K | 26.72%55.06K | 43.45K | |||||||
| Other cash income from operating activities | --12.66K | ---- | ---- | ---- | 26.72%55.06K | --43.45K | ---- | ---- | ---- | ---- |
| Cash paid | -44.72%-995.91K | -42.94%-688.18K | -3.14%-481.43K | 28.50%-466.78K | -31.19%-652.83K | -17.48%-497.61K | 0.64%-423.57K | -5.86%-426.3K | -2.11%-402.71K | -87.90%-394.38K |
| Payments to suppliers for goods and services | -44.72%-995.91K | -42.94%-688.18K | -3.14%-481.43K | 28.50%-466.78K | -31.19%-652.83K | -17.48%-497.61K | 0.64%-423.57K | -5.86%-426.3K | -2.11%-402.71K | -87.90%-394.38K |
| Direct interest received | 53.20%8.37K | -5.75%5.46K | 1,775.08%5.79K | -49.59%309 | -23.76%613 | -75.52%804 | -7.10%3.28K | -73.43%3.54K | 96.75%13.3K | -74.89%6.76K |
| Direct tax refund paid | ---- | ---- | ---- | ---- | ---- | --250K | ---- | ---- | ---- | ---- |
| Operating cash flow | -42.79%-974.88K | -43.54%-682.72K | -1.97%-475.64K | 21.89%-466.47K | -193.64%-597.16K | 51.61%-203.37K | 0.59%-420.28K | -8.57%-422.76K | -0.46%-389.4K | -155.51%-387.62K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 12.49%-1.37M | -47.83%-1.56M | -358.56%-1.06M | 183.40%409.25K | -129.75%-490.7K | 765.56%1.65M | -175.86%-247.83K | 64.42%-89.84K | -34.17%-252.52K | 28.31%-188.2K |
| Capital expenditure reported | 26.57%-1.37M | -46.33%-1.86M | -392.84%-1.27M | 70.86%-258.51K | -518.36%-887.11K | 42.11%-143.46K | -175.86%-247.83K | 65.11%-89.84K | -31.56%-257.52K | 25.44%-195.74K |
| Net PPE purchase and sale | ---- | --300K | ---- | ---- | ---- | --300K | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5K | ---- |
| Net investment purchase and sale | ---- | ---- | -67.67%215.88K | 68.45%667.75K | -73.45%396.41K | --1.49M | ---- | ---- | ---- | --7.53K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 12.49%-1.37M | -47.83%-1.56M | -358.56%-1.06M | 183.40%409.25K | -129.75%-490.7K | 765.56%1.65M | -175.86%-247.83K | 64.42%-89.84K | -34.17%-252.52K | 28.31%-188.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 118.64%3.03M | -21.10%1.39M | 76,976.26%1.76M | -101.55%-2.29K | -41.07%147.42K | 250.14K | 8.82%841.08K | 60.42%772.92K | 481.82K | |
| Net common stock issuance | 118.64%3.03M | -21.10%1.39M | 76,976.26%1.76M | -101.55%-2.29K | -41.07%147.42K | --250.14K | ---- | 8.82%841.08K | 174.26%772.92K | --281.82K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 118.64%3.03M | -21.10%1.39M | 76,976.26%1.76M | -101.55%-2.29K | -41.07%147.42K | --250.14K | ---- | 8.82%841.08K | 60.42%772.92K | --481.82K |
| Net cash flow | ||||||||||
| Beginning cash position | -65.67%449.51K | 20.68%1.31M | -5.20%1.08M | -45.11%1.14M | 436.42%2.08M | -63.22%388.67K | 45.10%1.06M | 21.93%728.29K | -16.03%597.29K | -36.80%711.29K |
| Current changes in cash | 180.14%689.04K | -483.19%-859.8K | 477.05%224.38K | 93.67%-59.51K | -155.44%-940.44K | 353.88%1.7M | -303.39%-668.11K | 150.74%328.49K | 239.36%131K | 77.31%-94K |
| End cash Position | 153.29%1.14M | -65.67%449.51K | 20.68%1.31M | -5.20%1.08M | -45.11%1.14M | 436.42%2.08M | -63.22%388.67K | 45.10%1.06M | 17.98%728.29K | -13.22%617.29K |
| Free cash from | 7.98%-2.34M | -45.57%-2.55M | -141.34%-1.75M | 51.16%-724.97K | -327.96%-1.48M | 48.09%-346.83K | -30.34%-668.11K | 20.76%-512.6K | -10.90%-646.92K | -40.83%-583.35K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |